7e2x: Difference between revisions

No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 7e2x is ON HOLD
==Apo serotonin 1A (5-HT1A) receptor-Gi protein complex==
<StructureSection load='7e2x' size='340' side='right'caption='[[7e2x]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[7e2x]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] and [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7E2X OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7E2X FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=J40:[(2~{R})-1-[oxidanyl-[(2~{R},3~{R},5~{S},6~{R})-2,3,5,6-tetrakis(oxidanyl)-4-phosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-3-tetradecanoyloxy-propan-2-yl]+(5~{E},8~{E})-hexadeca-5,8,11,14-tetraenoate'>J40</scene>, <scene name='pdbligand=PLM:PALMITIC+ACID'>PLM</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7e2x FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7e2x OCA], [https://pdbe.org/7e2x PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7e2x RCSB], [https://www.ebi.ac.uk/pdbsum/7e2x PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7e2x ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/GNAI1_HUMAN GNAI1_HUMAN] Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G(i) proteins are involved in hormonal regulation of adenylate cyclase: they inhibit the cyclase in response to beta-adrenergic stimuli. The inactive GDP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane. May play a role in cell division.<ref>PMID:17635935</ref> <ref>PMID:17264214</ref>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Serotonin, or 5-hydroxytryptamine (5-HT), is an important neurotransmitter(1,2) that activates the largest subtype family of G-protein-coupled receptors(3). Drugs that target 5-HT(1A), 5-HT(1D), 5-HT(1E) and other 5-HT receptors are used to treat numerous disorders(4). 5-HT receptors have high levels of basal activity and are subject to regulation by lipids, but the structural basis for the lipid regulation and basal activation of these receptors and the pan-agonism of 5-HT remains unclear. Here we report five structures of 5-HT receptor-G-protein complexes: 5-HT(1A) in the apo state, bound to 5-HT or bound to the antipsychotic drug aripiprazole; 5-HT(1D) bound to 5-HT; and 5-HT(1E) in complex with a 5-HT(1E)- and 5-HT(1F)-selective agonist, BRL-54443. Notably, the phospholipid phosphatidylinositol 4-phosphate is present at the G-protein-5-HT(1A) interface, and is able to increase 5-HT(1A)-mediated G-protein activity. The receptor transmembrane domain is surrounded by cholesterol molecules-particularly in the case of 5-HT(1A), in which cholesterol molecules are directly involved in shaping the ligand-binding pocket that determines the specificity for aripiprazol. Within the ligand-binding pocket of apo-5-HT(1A) are structured water molecules that mimic 5-HT to activate the receptor. Together, our results address a long-standing question of how lipids and water molecules regulate G-protein-coupled receptors, reveal how 5-HT acts as a pan-agonist, and identify the determinants of drug recognition in 5-HT receptors.


Authors: Xu, P., Huang, S., Zhang, H., Mao, C., Zhou, X.E., Shen, D.D., Jiang, Y., Zhang, Y., Xu, H.E.
Structural insights into the lipid and ligand regulation of serotonin receptors.,Xu P, Huang S, Zhang H, Mao C, Zhou XE, Cheng X, Simon IA, Shen DD, Yen HY, Robinson CV, Harpsoe K, Svensson B, Guo J, Jiang H, Gloriam DE, Melcher K, Jiang Y, Zhang Y, Xu HE Nature. 2021 Apr;592(7854):469-473. doi: 10.1038/s41586-021-03376-8. Epub 2021 , Mar 24. PMID:33762731<ref>PMID:33762731</ref>


Description: Apo serotonin 1A (5-HT1A) receptor-Gi protein complex
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: Zhang, Y]]
<div class="pdbe-citations 7e2x" style="background-color:#fffaf0;"></div>
[[Category: Zhou, X.E]]
 
[[Category: Huang, S]]
==See Also==
[[Category: Xu, H.E]]
*[[Transducin 3D structures|Transducin 3D structures]]
[[Category: Zhang, H]]
== References ==
[[Category: Xu, P]]
<references/>
[[Category: Shen, D.D]]
__TOC__
[[Category: Jiang, Y]]
</StructureSection>
[[Category: Mao, C]]
[[Category: Escherichia coli]]
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Huang S]]
[[Category: Jiang Y]]
[[Category: Mao C]]
[[Category: Shen DD]]
[[Category: Xu HE]]
[[Category: Xu P]]
[[Category: Zhang H]]
[[Category: Zhang Y]]
[[Category: Zhou XE]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA